2026 NPPES data Hematology & Oncology Physician NPI 1730229584 M.D.
Verify on CMS →

MICHAEL DIAZ, M.D.

Hematology & Oncology Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 193 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$212.13
8 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAEL DIAZ, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 3K claims across 193 beneficiaries — 18% brand-name prescribing . Industry payments of $212.13 across 8 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAEL DIAZ, M.D. filed 2,723 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MICHAEL DIAZ, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MICHAEL DIAZ, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 02/08/2007

NPI 1730229584

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

2,723 221% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers

Hematology & Oncology Physician share within New York

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL DIAZ, M.D. is a Hematology & Oncology Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1730229584. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL DIAZ, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 1112 PARK AVE, NEW YORK, NY, 10128, with a listed phone of (212) 876-4500. NPI 1730229584 was issued on 02/08/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DIAZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,723 prescription claims written by this provider, covering 193 Medicare beneficiaries and totaling roughly $540K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 3.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1112 PARK AVE
NEW YORK, NY 10128

Provider Details

NPI 1730229584
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 02/08/2007

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL DIAZ, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$212

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MICHAEL DIAZ, M.D.. To verify MICHAEL DIAZ, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MICHAEL DIAZ, M.D. — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 2,723 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,723
Total Claims
$540K
Total Drug Cost
193
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,201
Total Day Supply
150,791
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$440K
Generic Drug Cost
$98K
Opioid Claims
93 (3.4% rate)
Antibiotic Claims
87

Patient Demographics

Average Patient Age
72.7 years
Avg HCC Risk Score
1.70
Gender Split
59% female / 41% male
Age Distribution
<65: 18, 65-74: 99, 75-84: 53, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
130
Diclofenac Sodium
120
Amlodipine Besylate
107
Levothyroxine Sodium
80
Metformin Hcl
77
Tamsulosin Hcl
72
Metoprolol Succinate
63
Gabapentin
55
Jardiance
Empagliflozin
55
Rosuvastatin Calcium
52

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MICHAEL DIAZ, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MICHAEL DIAZ, M.D.'s 2,723 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as DIAZ.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL DIAZ, M.D.'s specialty?
MICHAEL DIAZ, M.D. specializes in Hematology & Oncology Physician and practices in NEW YORK, New York. Credentials: M.D..
How much does MICHAEL DIAZ, M.D. prescribe under Medicare Part D?
In 2023, MICHAEL DIAZ, M.D. wrote 2,723 Medicare Part D claims totaling $540K in drug costs for 193 beneficiaries.
Where is MICHAEL DIAZ, M.D. located?
MICHAEL DIAZ, M.D. is located at 1112 PARK AVE, NEW YORK, NY, 10128. Phone: (212) 876-4500.
What is MICHAEL DIAZ, M.D.'s NPI number?
MICHAEL DIAZ, M.D.'s National Provider Identifier (NPI) is 1730229584, issued on 02/08/2007.
Does MICHAEL DIAZ, M.D. prescribe more brand-name or generic drugs?
MICHAEL DIAZ, M.D.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $440K in brand drug costs.
Does MICHAEL DIAZ, M.D. prescribe opioids?
Yes, MICHAEL DIAZ, M.D. had 93 opioid claims in 2023 with an opioid prescribing rate of 3.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MICHAEL DIAZ, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL DIAZ, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Diclofenac Sodium, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL DIAZ, M.D. accept Medicare?
MICHAEL DIAZ, M.D. appears in CMS Medicare data with 2,723 Part D claims and 193 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL DIAZ, M.D.'s credentials?
MICHAEL DIAZ, M.D.'s NPI is 1730229584 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology